Dover Corporation (DOV) — BATS 19/100 — 2026-07-23

Listen to the earnings call audio for free on StockAnalysis

Summary based on Dover Corporation earnings call on 2026-07-23

BotFlo AI Transformation Score for $DOV: 19 (19/100)

Sector AI Transformation Score for $DOV: 7 (7/50)

Presentation

(1/6) Q2 2026 consolidated results and guidance raise
• 📈 All-in revenue grew 7% or 5% organically, with all five segments posting positive organic growth and adjusted EPS of $2.74, up 12% year-over-year.
• 📦 Orders increased 16% year-over-year with book-to-bill at 1.06, extending order momentum and second-half visibility.
• 💰 Given first-half performance and end-market momentum, Dover raised full-year adjusted EPS guidance while targeting double-digit EPS growth.

(2/6) Segment performance across the portfolio
• 🛠️ Engineered Products rose 2% organically on aerospace and defense, fluid dispensing, industrial winches, and stabilizing North American vehicle aftermarket, with margins up 100 basis points.
• ⚡ Clean Energy & Fueling grew 9% organically and Imaging & Identification 3%, while Pumps & Process Solutions saw strength in AI and energy infrastructure components, biopharma, and industrial pumps.
• 🏭 Climate & Sustainability Technologies grew 8% organically as heat exchange posted its best quarter on liquid-cooling demand, while Refrigeration throughput lagged during a complex facility consolidation.

(3/6) Cash flow and capital deployment
• 💵 Year-to-date free cash flow was $320 million, or 8% of revenue, up 23% over prior year on earnings conversion despite growth-related working capital.
• 📅 Cash generation is expected to accelerate in the second half on seasonal working capital liquidation, with CapEx still $190–$210 million and FCF guidance 14%–16% of revenue.
• 🏗️ Dover advanced capacity expansion and productivity investments and noted an improved industrial M&A pipeline alongside balance-sheet flexibility.

(4/6) Bookings breadth and secular growth priorities
• 📊 All five segments posted year-over-year booking growth, with trailing-twelve-month consolidated bookings up 15% and book-to-bill well above 1.
• 🚀 Particular strength is cited in aerospace and defense, turbine and power-generation components, single-use biopharma, CO2 refrigeration, and heat exchangers for data-center liquid cooling.
• 🔄 Recovery signals also appeared in refrigerated door cases and engineering services, while polymer processing book-to-bill above 1 hinted at stabilization into 2027.

(5/6) Secular end-market exposures and data-center ecosystem
• 📡 Secular growth markets now represent about 25% of 2026 revenue, spanning LNG/cryogenic components, turbine precision parts, electrification test equipment, biopharma, space, and data centers.
• ❄️ In data centers, chip thermal density is driving liquid cooling demand that benefits connectors and brazed-plate heat exchangers in CDUs and chillers, plus OPW couplers, cryogenic infrastructure, and fiberglass trench systems.
• 🎯 Dover expects about $50 million of space-related revenue this year and continues to prioritize these technically demanding, mission-critical component markets in M&A.

(6/6) Updated full-year outlook and operating stance
• 📈 Updated guidance raises organic growth and adjusted EPS outlook, with positive organic growth expected in all five segments.
• ⚠️ Management still flags geopolitics, input costs, and trade/tariff uncertainty while citing constructive demand and order-book duration as support for the increase.
• 🧭 Dover emphasizes disciplined operations, investment in high-return platforms, and balance-sheet flexibility for offensive capital deployment.

Q&A

(1/18) Q&A: Refrigeration throughput impact and customer disruption
• 📉 The 1 to 1.5 points of organic growth impact from refrigeration throughput issues is on a Dover consolidated basis.
• 🚚 Some deliveries have been late, but industry capacity is tight and management is not aware of lost market share to date.
• 🔧 Margin pressure from redundant facilities was expected; disappointing throughput is the issue, with all hands on deck for Q3–Q4 catch-up and the old plant about three-quarters closed.

(2/18) Q&A: Polymer weakness inside Pumps & Process
• 📉 Polymer processing tends to be lumpy and faced a tough prior-year comparison after driving a large Q4 beat.
• 💰 Weaker polymer revenue was detrimental to the top line but helped consolidated margin versus plan, with profit slightly above expectations.
• 📊 Polymer book-to-bill exited Q2 above 1, a constructive signal.

(3/18) Q&A: CO2 adoption and EPA mandate timing
• ⏱️ Dover could not meet all CO2 delivery obligations in Q2, but backlog looks strong and management does not believe it is losing share.
• 📈 Adoption is actually accelerating and is now driven more by economics than regulation.
• ✅ Management is pleased there is not a hard time-based mandate because the industry could not have met one, making a multiyear adoption path better for Dover.

(4/18) Q&A: Cryogenic products opportunity in data centers
• ❄️ Cryogenic valves, connectors, and piping acquired for LNG/natural gas are increasingly viable in data-center cooling applications.
• 🔄 Dover is pivoting to recognize the data-center opportunity even though the original thesis was natural gas and LNG.
• 🆕 The application is relatively new, which is why it had not been emphasized on prior calls.

(5/18) Q&A: Sequential orders versus book-to-bill momentum
• 📊 As revenue rises the book-to-bill bogey gets larger, and management had already signaled Q1 strength could drift lower as long as book-to-bill stayed above 1.
• 🌐 Book-to-bill remains above 1 across the entire portfolio, which historically is uncommon for Dover and indicates breadth.
• 🧭 Management views further dissection of the sequential numerator decline as over-picking a still-solid orders picture.

(6/18) Q&A: SWEP capacity increase timing and constrained growth
• 🏭 SWEP capacity is coming on sequentially over the balance of the second half into 2027, discussed only in general terms for competitive reasons.
• 📈 Second-quarter growth would have been higher if that capacity had already been available.
• ⏳ The ramp is phased rather than a single step-change, extending from late 2026 into 2027.

(7/18) Q&A: Refrigeration catch-up and margin recovery path
• 🔧 Throughput is expected to increase sequentially over the balance of the year and flow through fixed-cost absorption into margins.
• 📉 Management prefers not to quantify the exact margin hit but says closing remaining redundancy costs plus higher throughput should lift Refrigeration margins.
• 💰 H2 profitability is expected to be materially different from H1 as the transition completes.

(8/18) Q&A: Incremental margins ex-refrigeration and H2 trajectory
• 📈 Company-level incrementals rose from 25% to 38%, reflecting strength across the portfolio once refrigeration drag is considered.
• 🛠️ Each business has an earnings-growth plan via mix, restructuring benefits, and avoiding dilutive volume, including cryogenic margin recovery in clean energy.
• ⚖️ Catching up refrigeration should boost top line and may be somewhat dilutive to consolidated margins, which is acceptable relative to portfolio trajectory.

(9/18) Q&A: Why 2x heat-exchanger capacity and margin dilution from ramps
• 🛡️ Heat-exchange capacity is inherently hard to ramp, which supports the defensive competitive position and makes 2x a deliberate pace.
• 🏗️ Dover has been adding capacity for roughly 2.5 years ahead of revenue, which previously diluted margins.
• 📈 Demand has now inflected enough that revenue is accelerating faster than capital deployment, so margins are expanding.

(10/18) Q&A: M&A market improvement versus buybacks
• 🛒 More industrial assets are coming to market than in the prior two to three years, improving the opportunity set if prices allow value creation.
• 💵 If Dover does not deploy on M&A it will not sit on another year of cash and would return capital, but posture has shifted toward keeping powder dry.
• ⚖️ Versus late last year, more assets and still-high but potentially workable multiples make acquisition screening preferable to defaulting to repurchases.

(11/18) Q&A: Clean Energy growth mix between retail fueling and cryogenic
• ⛽ Retail fueling strength is broad-based after years of 80/20 portfolio work and continued product investment through the down cycle.
• 🏭 Acquisition-built clean energy/cryogenic operations required multiyear facility consolidation similar in difficulty to refrigeration.
• 📈 Both end-market demand inflection and margin recovery are now visible across both sides of Clean Energy.

(12/18) Q&A: Biopharma orders versus large capital-equipment peers
• 🧬 Dover’s biopharma exposure is largely consumables and replacement products tied to systems already running, not primarily new capital systems.
• 🔄 When OEM consumable activity is healthy, Dover’s connectors, pumps, and flow meters benefit from ongoing production.
• 🆕 New product introductions, including launches in the current week, have been very successful and support outperformance.

(13/18) Q&A: Why bookings growth is not fully torquing revenue yet
• 🎯 Management is intentionally not talking up revenue beyond the raised full-year guide to avoid estimates outrunning guidance.
• 📅 If orders still chug into the end of Q3, Dover is willing to revisit the top line then.
• 🗓️ July order trends were not yet closed and therefore not characterized.

(14/18) Q&A: Lead-time extension and backlog visibility
• ⏱️ Overall lead times are in balance except where execution problems pushed shipments into backlog.
• 📅 The only material elongation into 2027 is in long-cycle pockets and is not large relative to total backlog.
• ❄️ In heat exchangers, customers are ordering ahead to secure supply because market demand exceeds industry capacity, not because Dover lead times alone stretched.

(15/18) Q&A: Durability of the cycle beyond 2026
• 🔭 Cycles Dover is in clearly have visibility into 2027, though duration beyond that remains the open question.
• ⚖️ Data center, space launch, and biopharma exposures are meaningful but proportionate portfolio participations rather than single-thesis bets.
• 📈 No business currently looks like short-cycle demand that ends in 2026; strategic planning assumes trajectories may change but not turn negative into 2027.

(16/18) Q&A: Order conversion into faster organic and earnings growth
• ⚠️ Rolling twelve-month conversion can look clean, but short-cycle mix creates quarterly volatility, so management avoids getting ahead of its skis.
• 🏭 The priority is converting orders as fast as manufacturing allows—days and weeks, not waiting quarters—within current business forecasts.
• 🔄 If orders continue to surge and book-to-bill stays strong through Q3, guidance can be revisited to the extent capacity can convert backlog.

(17/18) Q&A: Concern about SWEP capacity ramp versus refrigeration issues
• 🤖 Management always has some ramp concern, but less for SWEP because it is the highest automated business in the portfolio.
• 👷 Refrigeration problems have been largely driven by labor ramp, a different constraint than SWEP’s automated model.
• 🏭 Therefore the SWEP capacity add is viewed as lower operational risk than the refrigeration consolidation.

(18/18) Q&A: Forward heat-exchanger orders and capacity timeline
• 📅 Customers continued placing baseplate heat-exchanger orders further into the future in Q2, as they had begun in Q1.
• 🏗️ Capacity will come on sequentially over the back half of 2026 into 2027.
• 🚫 Management declined to give quarterly organic sequencing or confirm Q3 versus Q4 patterns, citing no quarterly guidance.